PAIN INTER- RUPTED LIFE TRANSFORMED

whitePaper | March 23, 2023

DCTs can take a variety of forms depending on patients’ needs, study protocol, drug company preferences, or regulatory requirements. Trials may be remote and decentralised from start to finish with no physical contact between participants and investigators or they may rely on hybrid designs that incorporate only certain elements of decentralisatio

whitePaper | July 26, 2022

Healthcare leaders have long recognized the importance of real-time decision making. Take, for instance, sepsis one of the leading causes of U.S. hospital deaths that costs the industry an estimated $62B a year,1 not to mention the preventable morbidity

whitePaper | January 19, 2023

Successful execution of clinical trials requires the orchestration of multiple moving parts, with everything from protocol design and patient visit schedules.

whitePaper | July 8, 2022

Before the onset of the coronavirus pandemic, forces at the federal level were in motion to transform the healthcare industry from a closed to a more open system.

whitePaper | November 24, 2022

The life sciences industry has been exploring ways to accelerate the study start up process for well over a decade. The industry has long understood the value behind faster clinical trials: the sooner clinical trial results can be delivered to agencies

whitePaper | November 5, 2022

IQVIA enabled the successful adoption of a new HIS in Ministry of Health hospitals across three regions in Kingdom of Saudi Arabia with innovative change management models.